X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Biopharmaceutical industry is essential to development of Alzheimer’s treatments

By Holly Campbell  |    December 23, 2015
This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a better treatment...   Read More

Upcoming symposium: Building Community Health & Wellbeing

By Guest Contributor  |    December 23, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Local Impact: Hepatitis C and Medicaid spending

By Priscilla VanderVeer  |    December 22, 2015
There has been a lot of discussion about the cost of new hepatitis C treatments to state Medicaid programs. What has not been addressed, however, is how those costs stack up against older, less...   Read More

Pacira settlement important step towards ensuring clinicians have access to the best available data on FDA-approved medicines

By Mit Spears  |    December 22, 2015
During last week’s FDA/CMS Summit for Biopharma Executives, I had the opportunity to discuss the many recent legal and regulatory developments regarding communicating scientific data and clinical...   Read More

PhRMA Statement on Medicare Drug Spending Dashboard

By Robert Zirkelbach  |    December 21, 2015
The prescription drug spending data released by the Centers for Medicare & Medicaid Services (CMS) today provide a misleading and incomplete picture of actual Medicare spending on prescription...   Read More

Medicare Monday: 3 Medicare videos

By Allyson Funk  |    December 21, 2015
As the year comes to a close we want to wrap up with some of our favorite posts from 2015. This week we’re reminding you of our three favorite videos from this year. 5 Things You Might Not Know...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    December 18, 2015
Biologics and Biosimilars: PhRMA launched a new section of its website this week to provide educational resources on biologics and biosimilars. Check it out now. Ask About Adherence: Recent research...   Read More

Burden on Patients: 5 Questions on access to rheumatoid arthritis medicines in health exchange plans

By Allyson Funk  |    December 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to rheumatoid...   Read More

PhRMA launches biologics and biosimilars online resources

By Andrew Powaleny  |    December 17, 2015
Biological medicines often represent the cutting-edge of biomedical research and have revolutionized the treatment of a variety of medical illnesses and conditions that presently have no other...   Read More

Ask About Adherence: Q&A with Dr. Helaine Resnick on diabetes care

By Samantha Dougherty  |    December 17, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Helaine E. Resnick, PhD, MPH about her recently published literature review with...   Read More

Local Impact: State-by-state Medicaid spending on prescription medicines

By Rachel Licata  |    December 16, 2015
We’ve talked before about how prescription medicines comprise a small share of Medicaid spending. In recent years new life-changing, innovative medicines have come to market to help patients live...   Read More

ICYMI – WSJ commentary: The folly of targeting big pharma

By Holly Campbell  |    December 15, 2015
In case you missed it, the Wall Street Journal published commentary last week explaining the vital role of medicine development in reducing health care costs and spending. In the piece, Michael...   Read More

Policies to combat prescription drug abuse and misuse

By Priscilla VanderVeer  |    December 15, 2015
There has been a lot of discussion recently about prescription drug abuse, and rightfully so. Each day, almost 7,000 people are treated in emergency departments for using prescription opioid drugs in...   Read More

Join “I’m Not Average,” a community for patients and supporters

By Ieva M. Augstums  |    December 15, 2015
Every patient has a story. This is the core belief that inspired the creation of “I’m Not Average,” an online campaign committed to sharing stories of hope in the face of illness thanks – in part –...   Read More

Medicare Monday: More medicines in development for heart disease, stroke and other cardiovascular diseases

By Allyson Funk  |    December 14, 2015
When Medicare Part D beneficiaries have access to the medicines they need and take them as prescribed, both the individual and the broader health care system benefit in the form of better health and...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    December 11, 2015
Part D’s Six Protected Classes: The latest Conversations forum asks leading health experts why Medicare Part D’s protected classes are important for patients. See what they had to say.  Critics Wrong...   Read More

Trade Facilitation and Enforcement Act will strengthen IP enforcement

By Mark Grayson  |    December 11, 2015
This week, a conference committee reported out H.R. 644, the Trade Facilitation and Trade Enforcement Act of 2015.  This bill will provide much needed tools for the Customs and Border Control (CBP)...   Read More

Medicare Part D’s six protected classes

By Andrew Powaleny  |    December 10, 2015
Since Medicare Part D was created, seniors and people living with disabilities have been assured appropriate access to six specific classes of medicines (also known as the protected classes). The six...   Read More

Critics proven wrong again on medicine spending

By Holly Campbell  |    December 9, 2015
Recent comments from pharmacy benefit managers and insurers disprove – once again – the fallacious claims previously made about spending on new innovative medicines. Over the past year, payers...   Read More

New PhRMA Report: Nearly 200 medicines in development for heart disease, stroke and other cardiovascular diseases

By Ieva M. Augstums  |    December 9, 2015
Despite significant decreases in death rates from heart disease and stroke over the past three decades, these two conditions continue to be leading causes of death in the United States. With more...   Read More

Pharmaceutical industry increases investment in neglected tropical diseases by 28%

By Mark Grayson  |    December 8, 2015
Medical research and development (R&D) is a difficult concept for many to translate into a tangible outcome. Yet the future of medical innovation and the new medicines it spawns is very much...   Read More

Welcome news in two high-profile cancer battles

By Tina Stow  |    December 8, 2015
America’s biopharmaceutical companies are proud to be at the forefront of the battle against cancer, working tirelessly to develop innovative approaches for more effective treatments for patients. ...   Read More

Medicare Monday: Open enrollment ends today

By Andrew Powaleny  |    December 7, 2015
Medicare’s open enrollment ends today, December 7, 2015. That means today is the last day for seniors and people living with disabilities to shop around and change their coverage for next year. For...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    December 4, 2015
Ask About Adherence: A recent study from the American Journal of Preventive Medicine found proper adherence to hypertension medication leads to time, money and resources saved for both patients and...   Read More

Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans

By Allyson Funk  |    December 4, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to multiple...   Read More

Ask About Adherence: New study shows impact on preventable hospital visits

By Samantha Dougherty  |    December 3, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts and new studies in medication adherence. In this post, we spotlight a new study released by the American Journal of Preventive...   Read More

Direct-to-consumer advertising makes doctors and patients stronger partners

By Josephine Martin  |    December 2, 2015
The New York Times’ editorial board is right when it notes that direct-to-consumer (DTC) pharmaceutical advertising helps “educate and inform patients about drugs their doctors might not mention,...   Read More

Improving PDMPs: Strengthening state tools to prevent prescription drug abuse

By Guest Contributor  |    December 2, 2015
The problem of prescription drug abuse is complex and multi-faceted, and addressing the issue requires a multi-pronged, sustained approach involving a broad range of stakeholders. PhRMA and its...   Read More

What you need to know about access to innovative medicines in the U.S.

By Robert Zirkelbach  |    December 1, 2015
Today the Wall Street Journal published another story on prescription drug spending that cherry-picks Medicare Part B data in an effort to compare medicine prices in the U.S. to other countries. The...   Read More

World AIDS Day: Making progress

By Andrew Powaleny  |    December 1, 2015
Today is World AIDS Day and for many Americans who are HIV positive or who have AIDS, the outlook for those living with the disease has never – thankfully – been more promising. The HIV/AIDS epidemic...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."